Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
Launched by UNIVERSITY OF COLORADO, DENVER · Oct 22, 2014
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The "Healthy Start" study is looking at how the nutrition that mothers receive during pregnancy affects the health of their babies as they grow. Researchers want to see if giving babies too much nutrition while they are still in the womb can lead to problems like obesity or heart issues later in life. This study will involve a diverse group of pregnant women and their children over a long period to really understand these effects.
To participate in this study, pregnant women who live in Colorado and are less than 23 weeks along in their pregnancy can sign up. However, women who are pregnant with more than one baby (like twins or triplets), have certain preexisting health issues (like cancer or severe asthma), or have had complications in previous pregnancies are not eligible. Participants can expect to be part of a supportive research team that will monitor their health and their baby's health over time. This study aims to help improve the health of future generations by understanding the impacts of nutrition during pregnancy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women and infants
- • Prior to 23 completed weeks of gestation
- • Live in Colorado
- Exclusion Criteria:
- • Multiple gestation
- • Preexisting
- • cancer
- • psychiatric disease
- • steroid-dependent asthma, or
- • diabetes
- • Previous premature delivery prior to 25 weeks gestation or fetal demise
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Trial Officials
Dana Dabelea, MD, PhD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials